[go: up one dir, main page]

IN2012DN02591A - - Google Patents

Info

Publication number
IN2012DN02591A
IN2012DN02591A IN2591DEN2012A IN2012DN02591A IN 2012DN02591 A IN2012DN02591 A IN 2012DN02591A IN 2591DEN2012 A IN2591DEN2012 A IN 2591DEN2012A IN 2012DN02591 A IN2012DN02591 A IN 2012DN02591A
Authority
IN
India
Prior art keywords
proteins
plant
fraction
suprastructure
apoplast
Prior art date
Application number
Inventor
Louis-Philippe Vezina
Manon Couture
Dany Paquet
Michele Dargis
Aoust Marc-Andre D
Original Assignee
Medicago Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicago Inc filed Critical Medicago Inc
Publication of IN2012DN02591A publication Critical patent/IN2012DN02591A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8203—Virus mediated transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/517—Plant cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Water Supply & Treatment (AREA)
  • Analytical Chemistry (AREA)

Abstract

Methods of preparing plant-derived proteins or suprastructure proteins, are provided. The . method may comprise obtaining a plant, or plant matter comprising apoplast-localized proteins, or suprastructure proteins, producing a protoplast/spheroplast fraction and apoplast fraction from the plant or plant matter, and recovering the apoplast fraction. The apoplast fraction comprises plant-derived proteins or suprastructure proteins,. Alternatively, the proteins, or suprastructure proteins, may be obtained from plant or plant matter comprising plant-derived proteins or suprastructure proteins, by digesting the plant matter using a cell wall degrading enzyme composition to produced a digested fraction. The digested fraction is filtered to produced a filtered fraction, and the plant-derived proteins or suprastructure proteins, are recovered from the filtered fraction.
IN2591DEN2012 2009-09-22 2010-09-21 IN2012DN02591A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24478609P 2009-09-22 2009-09-22
PCT/CA2010/001489 WO2011035423A1 (en) 2009-09-22 2010-09-21 Method of preparing plant-derived proteins

Publications (1)

Publication Number Publication Date
IN2012DN02591A true IN2012DN02591A (en) 2015-08-28

Family

ID=43795254

Family Applications (2)

Application Number Title Priority Date Filing Date
IN2637DEN2012 IN2012DN02637A (en) 2009-09-22 2010-09-21
IN2591DEN2012 IN2012DN02591A (en) 2009-09-22 2010-09-21

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IN2637DEN2012 IN2012DN02637A (en) 2009-09-22 2010-09-21

Country Status (28)

Country Link
US (2) US11826419B2 (en)
EP (3) EP2480658B1 (en)
JP (2) JP5551780B2 (en)
KR (4) KR20180026562A (en)
CN (4) CN102549008A (en)
AR (2) AR078433A1 (en)
AU (2) AU2010300033B2 (en)
BR (2) BR112012006414B1 (en)
CA (2) CA2772964C (en)
DK (3) DK2480560T3 (en)
ES (3) ES2911037T3 (en)
HR (3) HRP20180509T1 (en)
HU (3) HUE038557T2 (en)
IL (4) IL218393A0 (en)
IN (2) IN2012DN02637A (en)
MX (2) MX2012003372A (en)
MY (2) MY164704A (en)
NO (2) NO2480560T3 (en)
NZ (2) NZ598481A (en)
PH (2) PH12012500565B1 (en)
PL (3) PL2480560T3 (en)
PT (3) PT2480560T (en)
RU (2) RU2567012C2 (en)
SG (2) SG178918A1 (en)
SI (3) SI2480560T1 (en)
TR (1) TR201803560T4 (en)
WO (2) WO2011035423A1 (en)
ZA (2) ZA201202836B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
US20100310604A1 (en) 2007-11-27 2010-12-09 Medicago Inc. Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
KR101377725B1 (en) 2009-06-24 2014-03-27 메디카고 인코포레이티드 Chimeric influenza virus-like particles comprising hemagglutinin
CN102549008A (en) * 2009-09-22 2012-07-04 麦迪卡格公司 Method for preparing protein of plant origin
TWI526539B (en) 2010-12-22 2016-03-21 苜蓿股份有限公司 Method for producing viroid-like particles (VLP) in plants and VLP produced by the method
TWI620816B (en) 2011-03-23 2018-04-11 苜蓿股份有限公司 Plant derived protein recovery method
PH12013502600A1 (en) * 2011-06-13 2022-04-08 Medicago Inc Rabies virus like particle production in plants
EP2758038B1 (en) * 2011-09-23 2018-05-30 The United States of America, as represented by The Secretary, Department of Health & Human Services Novel influenza hemagglutinin protein-based vaccines
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
KR101974017B1 (en) 2011-09-30 2019-04-30 메디카고 인코포레이티드 Increasing virus-like particle yield in plants
US20130167267A1 (en) * 2011-12-21 2013-06-27 Apse, Llc Processes using vlps with capsids resistant to hydrolases
JP6406655B2 (en) * 2012-02-22 2018-10-17 三菱商事フードテック株式会社 Method for softening vegetable food material, softened preparation, softened vegetable food material and food using the same
EP2827893B1 (en) * 2012-03-22 2017-11-29 Fraunhofer USA, Inc. Virus-like particles comprising a matrix protein from a plant enveloped virus and uses thereof
CN104755614B (en) 2012-09-05 2021-10-01 莫迪卡戈公司 Production of picornavirus-like particles in plants
US9617297B2 (en) * 2012-10-11 2017-04-11 The Regents Of The University Of California Apoplast wash fluid recovery for improved recombinant endoglucanase extraction in tabacco leaves
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
RU2705555C2 (en) * 2013-03-28 2019-11-07 Медикаго Инк. Obtaining virus-like particles of influenza virus in plants
JP6358257B2 (en) 2013-09-06 2018-07-18 三菱ケミカル株式会社 Protein production method using plants
US10744199B2 (en) 2013-10-11 2020-08-18 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Epstein-Barr virus vaccines
AU2015205805B2 (en) 2014-01-10 2020-11-12 Aramis Biotechnologies Inc. CPMV enhancer elements
AU2015286165B2 (en) 2014-07-11 2021-03-11 Medicago Inc. Modifying protein production in plants
IL294189B2 (en) 2014-12-31 2024-12-01 Us Health New vaccines based on multivalent nanoparticles
JP2019129705A (en) * 2016-03-31 2019-08-08 日本たばこ産業株式会社 Method for introducing substance into plant
IL303650B2 (en) 2016-09-02 2025-02-01 Us Health Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof
JP7579143B2 (en) * 2017-11-30 2024-11-07 アラミス バイオテクノロジーズ インコーポレイテッド Modified norovirus VP1 protein and VLP containing modified norovirus VP1 protein
JP2021528971A (en) 2018-06-27 2021-10-28 メディカゴ インコーポレイテッド Influenza virus hemagglutinin mutant
US11759512B2 (en) 2018-07-13 2023-09-19 Medicago Inc. Modified norovirus VP1 proteins and VLPs comprising modified norovirus VP1 proteins
CN109112093B (en) * 2018-09-05 2021-11-09 上海交通大学 Method for efficient separation and instantaneous transformation of artemisia apiacea protoplast
CA3137447A1 (en) * 2019-04-25 2020-10-29 Flagship Pioneering Innovations Vi, Llc Compositions and methods relating to plant messenger packs
CN110483616B (en) * 2019-07-31 2021-06-04 中国农业科学院农产品加工研究所 Method for separating apoplast effector protein secreted by pathogenic bacteria from plant tissue infected by pathogenic bacteria
CN111060696B (en) * 2019-12-27 2023-09-08 湖南农业大学 Method for reducing false positive rate of plant small molecule signal peptide
CN111718394A (en) * 2020-06-28 2020-09-29 广西壮族自治区农业科学院 Method for extracting sugarcane tissue denatured protein based on BPP method
CN111826394A (en) * 2020-08-07 2020-10-27 浙江华缔药业集团医药开发有限公司 Construction and application of plant transient expression vector
US12180492B2 (en) 2021-06-09 2024-12-31 Immunitybio, Inc. Methods and systems for producing a protein of interest in a plant
CN114934007B (en) * 2022-07-01 2023-11-24 广东省农业科学院作物研究所 Preparation method of sweet potato protoplast
JP7745040B1 (en) * 2024-06-21 2025-09-26 デンカ株式会社 Method for recovering and producing target protein
CN120082594B (en) * 2025-04-07 2025-10-28 贵州大学 Application of NbClpT2 in regulating plant resistance to PVY infection

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036006A (en) 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5100792A (en) 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
WO1986003224A1 (en) 1984-11-29 1986-06-05 Scripps Clinic And Research Foundation Polypeptides and antibodies related to deglycosylated viral glycoproteins
JPS61265086A (en) * 1985-05-21 1986-11-22 Mitsui Toatsu Chem Inc Method of cultivating protoplast
US5232833A (en) 1988-09-14 1993-08-03 Stressgen Biotechnologies Corporation Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
US6403865B1 (en) 1990-08-24 2002-06-11 Syngenta Investment Corp. Method of producing transgenic maize using direct transformation of commercially important genotypes
ATE142883T1 (en) 1991-03-28 1996-10-15 Rooperol Na Nv COMPOSITIONS OF PHYTOSTEROLS WITH PHYTOSTEROLINS AS IMMUNE MODULATORS
UA48104C2 (en) 1991-10-04 2002-08-15 Новартіс Аг Dna fragment including sequence that codes an insecticide protein with optimization for corn, dna fragment providing directed preferable for the stem core expression of the structural gene of the plant related to it, dna fragment providing specific for the pollen expression of related to it structural gene in the plant, recombinant dna molecule, method for obtaining a coding sequence of the insecticide protein optimized for corn, method of corn plants protection at least against one pest insect
US6326470B1 (en) 1997-04-15 2001-12-04 The Penn State Research Foundation Enhancement of accessibility of cellulose by expansins
US5762939A (en) 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
GB9414118D0 (en) 1994-07-13 1994-08-31 Axis Genetics Ltd Modified plant viruses as vectors of heterologous peptides
WO1997004122A1 (en) 1995-07-20 1997-02-06 Washington State University Research Foundation Production of secreted foreign polypeptides in plant cell culture
US5773695A (en) * 1996-01-26 1998-06-30 North Carolina State University Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells
US6042832A (en) 1996-08-28 2000-03-28 Thomas Jefferson University Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins
US20010006950A1 (en) 1998-02-11 2001-07-05 Juha Punnonen Genetic vaccine vector engineering
US6489537B1 (en) 1998-08-07 2002-12-03 The Trustees Of The University Of Pennsylvania Phytochelatin synthases and uses therefor
WO2000009725A2 (en) * 1998-08-11 2000-02-24 Biosource Technologies, Inc. Method for recovering proteins from the interstitial fluid of plant tissues
US6287570B1 (en) 1998-11-23 2001-09-11 Patricia L. Foley Vaccine against swine influenza virus
AU2594300A (en) 1998-12-23 2000-07-12 Samuel Roberts Noble Foundation, Inc., The Plant transformation process
FR2791358B1 (en) 1999-03-22 2003-05-16 Meristem Therapeutics CHEMICAL EXPRESSION PROMOTERS, EXPRESSION CASSETTES, PLASMIDS, VECTORS, PLANTS AND TRANSGENIC SEEDS CONTAINING THEM AND METHODS OF OBTAINING THEM
NZ513993A (en) 1999-04-21 2001-09-28 Samuel Roberts Noble Found Inc Plant transformation process
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
EP1310551A4 (en) * 2000-08-08 2004-09-22 Kitasato Inst VIRUS-LIKE MICROBALLS AND METHOD FOR THEIR PRODUCTION (02/15/02)
DK1362109T3 (en) 2001-01-18 2009-07-27 Vlaams Interuniv Inst Biotech Recombinant oligomeric protein complexes with enhanced immunogenic potential
EP1434800B1 (en) 2001-09-14 2010-12-01 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Immunoglobulin having particular framework scaffold and methods of making and using
EP1572910B1 (en) 2002-02-13 2015-12-02 Wisconsin Alumni Research Foundation Signal for packaging of influenza virus vectors
US20040121465A1 (en) 2002-02-14 2004-06-24 Novavax, Inc. Optimization of gene sequences of virus-like particles for expression in insect cells
AU2003219402B2 (en) 2002-03-19 2008-05-08 Stichting Dienst Landbouwkundig Onderzoek GnTIII (UDP-n-acethylglucosamine:beta-D mannoside beta (1,4)-N-acethylglucosaminy ltransferase III) expression in plants
KR20060035596A (en) 2003-05-05 2006-04-26 보이스 톰슨 인스터튜트 포 플랜트 리서치 Vectors and Cells for the Preparation of Immunoprotective Compositions Derived from Foreign Gene Transducing Plants
WO2004098530A2 (en) 2003-05-05 2004-11-18 Dow Agrosciences Llc Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
CA2529647C (en) 2003-06-16 2013-08-13 Medimmune Vaccines, Inc. Influenza hemagglutinin and neuraminidase variants
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
CN1560227A (en) * 2004-02-25 2005-01-05 福建师范大学 Preparation and regeneration technology of protoplasts from Haematococcus pluvialis
WO2006016380A2 (en) 2004-08-13 2006-02-16 Council Of Scientific And Industrial Research A chimeric g protein based rabies vaccine
US9155483B2 (en) 2004-12-03 2015-10-13 The Invention Science Fund I, Llc Vision modification with reflected image
JP5343212B2 (en) * 2005-03-15 2013-11-13 ヴェレニウム コーポレイション Cellulases, nucleic acids encoding them, and methods of making and using them
WO2006119516A2 (en) 2005-04-29 2006-11-09 University Of Cape Town Expression of viral proteins in plants
CN100410378C (en) 2005-05-09 2008-08-13 中国农业科学院生物技术研究所 Gene encoding avian influenza hemagglutinin and its plant expression vector and application
ATE523595T1 (en) * 2005-06-24 2011-09-15 Bayer Bioscience Nv METHOD FOR CHANGING THE REACTIVITY OF PLANT CELL WALLS
CA2615658A1 (en) 2005-07-19 2007-01-25 Dow Global Technolgies Inc. Recombinant flu vaccines
US7871626B2 (en) 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
CA2625406C (en) 2005-10-18 2016-08-09 Novavax, Inc. Functional influenza virus like particles (vlps)
EP2360175B1 (en) * 2005-11-22 2014-07-16 Novartis Vaccines and Diagnostics, Inc. Norovirus and Sapovirus virus-like particles (VLPs)
BRPI0707733B1 (en) 2006-02-13 2019-12-31 Ibio, Inc. isolated antigen, vaccine composition, use of said composition and method for producing an antigen protein
KR20080109094A (en) 2006-04-21 2008-12-16 다우 아그로사이언시즈 엘엘씨 Avian Influenza Vaccine and How to Use
WO2007130327A2 (en) 2006-05-01 2007-11-15 Technovax, Inc. Influenza virus-like particle (vlp) compositions
DK2023952T3 (en) 2006-05-18 2015-10-19 Epimmune Inc Induction of immune responses to influenza virus using polypeptide and nucleic acid compositions
WO2007135480A1 (en) 2006-05-22 2007-11-29 Plant Bioscience Limited Bipartite system, method and composition for the constitutive and inducible expression of high levels of foreign proteins in plants
US20070286873A1 (en) 2006-05-23 2007-12-13 Williams John V Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor
WO2008088813A1 (en) 2007-01-17 2008-07-24 Lerner Medical Devices, Inc. Fiber optic phototherapy device
US7730950B2 (en) 2007-01-19 2010-06-08 Halliburton Energy Services, Inc. Methods for treating intervals of a subterranean formation having variable permeability
SG185249A1 (en) 2007-06-15 2012-11-29 Medicago Inc Modifying glycoprotein production in plants
KR100964462B1 (en) 2007-07-10 2010-06-16 성균관대학교산학협력단 Avian Influenza Virus Vaccine Derived from Transgenic Plant and Its Manufacturing Method
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
RU2358981C2 (en) * 2007-08-07 2009-06-20 Центр "Биоинженерия" Российской Академии Наук Universal avian influenza virus vaccine
BRPI0815662A2 (en) 2007-08-20 2016-09-27 Fraunhofer Usa Inc flu vaccines, antigens, compositions, and prophylactic and therapeutic methods
CN101422128B (en) * 2007-10-29 2011-06-08 中国水产科学研究院黄海水产研究所 Separation and regeneration method of gulfweed protoplast
US20100310604A1 (en) 2007-11-27 2010-12-09 Medicago Inc. Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
WO2009083420A1 (en) * 2007-12-28 2009-07-09 Unilever Plc Process for recovering aroma from tea
US8799801B2 (en) 2008-01-16 2014-08-05 Qualcomm Incorporated Interactive ticker
EA034733B1 (en) 2008-01-21 2020-03-13 Медикаго Инк. Nucleic acid for increased expression of hemagglutinin of influenza virus in a plant and use thereof
CN102089432A (en) 2008-07-08 2011-06-08 麦迪卡格公司 Soluble recombinant influenza antigens
CN101626276A (en) 2008-07-10 2010-01-13 华为技术有限公司 Method, device and system for replacing advertisement
KR101745925B1 (en) 2008-07-18 2017-06-12 메디카고 인코포레이티드 New influenza virus immunizing epitope
US8513397B2 (en) 2008-08-27 2013-08-20 The Arizona Board Of Regents For And On Behalf Of Arizona State University DNA replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants
US20100167376A1 (en) * 2008-10-06 2010-07-01 Genvault Corporation Methods for providing cellular lysates from cell wall-containing samples
WO2010077712A1 (en) 2008-12-09 2010-07-08 Novavax, Inc. Bovine respiratory syncytial virus virus-like particle (vlps)
CN102365295A (en) 2009-01-30 2012-02-29 阿德利夫股份有限公司 Conformationally dynamic peptides
EP2440183B1 (en) 2009-06-10 2018-07-18 Arbutus Biopharma Corporation Improved lipid formulation
JP5886192B2 (en) 2009-06-10 2016-03-16 ノノ インコーポレイテッド Co-administration of internalized peptide-linked drugs and anti-inflammatory agents
KR101377725B1 (en) 2009-06-24 2014-03-27 메디카고 인코포레이티드 Chimeric influenza virus-like particles comprising hemagglutinin
CN102549008A (en) 2009-09-22 2012-07-04 麦迪卡格公司 Method for preparing protein of plant origin
ES2614527T3 (en) 2010-11-04 2017-05-31 Medicago Inc. Plant expression system
JP6158088B2 (en) 2010-11-05 2017-07-05 ノババックス，インコーポレイテッド Rabies glycoprotein virus-like particle (VLP)
TWI526539B (en) 2010-12-22 2016-03-21 苜蓿股份有限公司 Method for producing viroid-like particles (VLP) in plants and VLP produced by the method
TWI620816B (en) * 2011-03-23 2018-04-11 苜蓿股份有限公司 Plant derived protein recovery method

Also Published As

Publication number Publication date
HRP20220478T1 (en) 2022-05-27
EP2480658A4 (en) 2013-02-27
KR20180026562A (en) 2018-03-12
US20130067807A1 (en) 2013-03-21
SI3354657T1 (en) 2022-05-31
SI2480658T1 (en) 2017-11-30
SI2480560T1 (en) 2018-04-30
DK2480658T3 (en) 2017-11-06
HUE036776T2 (en) 2018-07-30
US11826419B2 (en) 2023-11-28
AU2010300033A1 (en) 2012-03-22
SG178947A1 (en) 2012-04-27
CA2772962C (en) 2013-04-02
ES2662778T3 (en) 2018-04-09
RU2012115661A (en) 2013-10-27
TR201803560T4 (en) 2019-01-21
DK3354657T3 (en) 2022-04-19
EP3354657A1 (en) 2018-08-01
BR112012006415B1 (en) 2020-04-28
EP2480560B1 (en) 2018-02-21
PL3354657T3 (en) 2022-05-09
NZ598508A (en) 2014-02-28
MX2012003373A (en) 2012-05-29
EP2480658A1 (en) 2012-08-01
HRP20180509T1 (en) 2018-05-04
JP2013505272A (en) 2013-02-14
KR101773431B1 (en) 2017-09-12
AR078432A1 (en) 2011-11-09
ES2911037T3 (en) 2022-05-17
CA2772964A1 (en) 2011-03-31
CN107129973A (en) 2017-09-05
SG178918A1 (en) 2012-04-27
CN107090021A (en) 2017-08-25
KR20120093223A (en) 2012-08-22
RU2579903C2 (en) 2016-04-10
NO2480658T3 (en) 2018-02-03
AU2010300033B2 (en) 2015-01-22
KR20190050862A (en) 2019-05-13
US11833200B2 (en) 2023-12-05
IL257261A (en) 2018-03-29
KR102115226B1 (en) 2020-05-27
ZA201202836B (en) 2012-12-27
IL218422B (en) 2018-03-29
CN102549008A (en) 2012-07-04
EP2480560A1 (en) 2012-08-01
RU2567012C2 (en) 2015-10-27
MY158475A (en) 2016-10-14
HUE038557T2 (en) 2018-10-29
IL218393A0 (en) 2012-04-30
US20120178149A1 (en) 2012-07-12
AR078433A1 (en) 2011-11-09
WO2011035422A1 (en) 2011-03-31
NZ598481A (en) 2014-02-28
BR112012006414A8 (en) 2017-10-10
CA2772962A1 (en) 2011-03-31
IN2012DN02637A (en) 2015-09-04
EP3354657B1 (en) 2022-01-26
PH12012500565B1 (en) 2018-01-12
BR112012006415A2 (en) 2016-11-16
AU2010300034B2 (en) 2015-07-30
PT3354657T (en) 2022-05-06
JP5551780B2 (en) 2014-07-16
KR20120072371A (en) 2012-07-03
JP5554414B2 (en) 2014-07-23
NO2480560T3 (en) 2018-07-21
PH12012500566A1 (en) 2012-10-22
MX2012003372A (en) 2012-05-29
IL218422A0 (en) 2012-04-30
DK2480560T3 (en) 2018-04-16
ZA201202835B (en) 2015-08-26
PL2480560T3 (en) 2018-06-29
JP2013505025A (en) 2013-02-14
PT2480658T (en) 2017-11-13
RU2012115996A (en) 2013-10-27
EP2480658B1 (en) 2017-09-06
IL270661B (en) 2021-12-01
PH12012500565A1 (en) 2012-10-22
IL257261B (en) 2020-03-31
PL2480658T3 (en) 2017-12-29
BR112012006414B1 (en) 2020-09-15
BR112012006414A2 (en) 2016-11-16
PT2480560T (en) 2018-04-03
CN102549148A (en) 2012-07-04
ES2642631T3 (en) 2017-11-17
CA2772964C (en) 2020-10-27
WO2011035423A1 (en) 2011-03-31
EP2480560A4 (en) 2013-01-23
HRP20171564T1 (en) 2017-11-17
AU2010300034A1 (en) 2012-03-22
HUE058165T2 (en) 2022-07-28
MY164704A (en) 2018-01-30

Similar Documents

Publication Publication Date Title
MY158475A (en) Method of preparing plant-derived proteins
EA201200772A1 (en) METHOD OF OBTAINING HOLLOW MICROSPHERES
PL2167631T3 (en) Biogas plant and process for the production of biogas from ligneous renewable resources
WO2012151524A3 (en) Lignin production from lignocellulosic biomass
SG10201407242RA (en) Candida tropicalis cells and use thereof
ZA201109250B (en) Method for production of fermentable sugars from biomass
WO2012126123A8 (en) Method of recovering plant-derived proteins
MY152682A (en) Swollenin compositions and methods of increasing the efficency of a cellulase
EA201101213A1 (en) COMPOSITIONS AND METHODS OF DEGRADATION OF LYNNOCELLULUS BIOMASS
MY170602A (en) Process for fractionation of biomass
WO2010149614A3 (en) Run-up method for a solar steam power plant
MX2012001537A (en) Method for capturing co2 produced by cement plants by using the calcium cycle.
WO2011051977A3 (en) Process for biodiesel production from a yeast strain
WO2010079069A3 (en) Process, plant, and biofuel from lignocellulosic feedstock
WO2010128518A3 (en) Novel process for the preparation of cisatracurium besylate
UA108343C2 (en) Method of producing squalene using yeast
TW201129535A (en) Alcoholic hydroxyl-containing compounds and making method
WO2010058427A3 (en) Process for production and purification of polymyxin b sulfate
NZ598995A (en) Producing edible residues from ethanol production
HK1199473A1 (en) Production of bio-butanol and related products
MX2014010628A (en) Process for the production of organic compounds from plant species.
WO2011124815A3 (en) Method for obtaining a fermentable product from polluted ligno-cellulosic biomass
WO2012089843A3 (en) Extraction of scenedesmus cell components
WO2010100066A3 (en) Wind power plant and related production method
WO2008143204A1 (en) Ethanol production method and diesel fuel production method both using trunk of oil palm tree as raw material